Ocular Therapeutix (OCUL) Enterprise Value Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -90.66% |
| Dec 31, 2025 | -87.98% |
| Sep 30, 2025 | 19.30% |
| Jun 30, 2025 | 14.91% |
| Mar 31, 2025 | 27.61% |
| Dec 31, 2024 | -100.10% |
| Sep 30, 2024 | -286.45% |
| Jun 30, 2024 | -590.16% |
| Mar 31, 2024 | -511.24% |
| Dec 31, 2023 | -91.55% |
| Sep 30, 2023 | 8.60% |
| Jun 30, 2023 | 50.49% |
| Mar 31, 2023 | 45.66% |
| Dec 31, 2022 | 37.68% |
| Sep 30, 2022 | 32.54% |
| Jun 30, 2022 | 29.88% |
| Mar 31, 2022 | 30.55% |
| Dec 31, 2021 | 28.02% |
| Sep 30, 2021 | -153.79% |
| Jun 30, 2021 | -127.61% |
| Mar 31, 2021 | -334.83% |
| Dec 31, 2020 | -318.94% |
| Sep 30, 2020 | -7.99% |
| Jun 30, 2020 | -36.48% |
| Mar 31, 2020 | 36.85% |
| Dec 31, 2019 | -0.69% |
| Sep 30, 2019 | -15.04% |
| Jun 30, 2019 | -8.68% |
| Mar 31, 2019 | -21.20% |
| Dec 31, 2018 | -30.15% |
| Sep 30, 2018 | -11.13% |
| Jun 30, 2018 | 13.95% |
| Mar 31, 2018 | 21.73% |
| Dec 31, 2017 | 39.04% |
| Sep 30, 2017 | 32.45% |
| Jun 30, 2017 | 21.26% |
| Mar 31, 2017 | 15.79% |
| Dec 31, 2016 | 35.14% |
| Sep 30, 2016 | 33.35% |
| Jun 30, 2016 | 32.20% |
| Mar 31, 2016 | -41.58% |
| Dec 31, 2015 | -40.41% |
| Sep 30, 2015 | -40.49% |
| Jun 30, 2015 | -520.35% |
| Mar 31, 2015 | -428.81% |
| Dec 31, 2014 | -327.47% |
| Sep 30, 2014 | -274.21% |
| Jun 30, 2014 | 20.32% |